Inventor · disambiguated record
Matthew H. Daniels
Also filed as: DANIELS MATTHEW · DANIELS MATTHEW H · DANIELS MATTHEW HERSH
19 granted patents·12 pending applications·62 citations·filing 2010–2024
91Inventor score
Files withGOLDFINCH BIO INC9MERCK SHARP & DOHME8ACCENT THERAPEUTICS INC6WILSON KEVIN2DANIELS MATTHEW1
Top patents by PatentIndex Score
31 records- 0194US9663522B23-aminocycloalkyl compounds as RORgammaT inhibitors and uses thereofMERCK SHARP & DOHME·Filed 2013·Granted May 30, 2017·15 cites·22 claims
- 0293US11046690B2Pyridazinones and methods of use thereofGOLDFINCH BIO INC·Filed 2020·Granted Jun 29, 2021·4 cites·20 claims
- 0392US10221146B2Tetrahydronaphthyridine, benzoxazine, aza-benzoxazine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of diseaseMERCK SHARP & DOHME·Filed 2017·Granted Mar 5, 2019·6 cites·18 claims
- 0492US9809561B2Tetrahydronaphthyridine, benzoxazine, aza-benzoxazine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of diseaseMERCK SHARP & DOHME·Filed 2014·Granted Nov 7, 2017·8 cites·16 claims
- 0592US9663502B22-Acylamidomethyl and sulfonylamidomethyl benzoxazine carbamates for inhibition of RORgamma activity and the treatment of diseaseMERCK SHARP & DOHME·Filed 2014·Granted May 30, 2017·12 cites·26 claims
- 0691US9783511B2Carbamate benzoxazine propionic acids and acid derivatives for modulation of RORgamma activity and the treatment of diseaseMERCK SHARP & DOHME·Filed 2014·Granted Oct 10, 2017·9 cites·21 claims
- 0790US10654850B2Pyridazinones and methods of use thereofGOLDFINCH BIO INC·Filed 2019·Granted May 19, 2020·4 cites·4 claims
- 0885US12233065B2Inhibitors of RNA helicase DHX9 and uses thereofACCENT THERAPEUTICS INC·Filed 2024·Granted Feb 25, 2025·0 cites·16 claims
- 0982US12162867B2Inhibitors of RNA helicase DHX9 and uses thereofACCENT THERAPEUTICS INC·Filed 2024·Granted Dec 10, 2024·0 cites·16 claims
- 1081US9023865B2Compounds that are ERK inhibitorsLIM JONGWON·Filed 2012·Granted May 5, 2015·4 cites·20 claims
- 1180US2025145597A1Inhibitors of rna helicase dhx9 and uses thereofACCENT THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1267US12466834B2Imidazodiazepinediones and methods of use thereofGFB ABC LLC·Filed 2023·Granted Nov 11, 2025·0 cites·17 claims
- 1367US2022024917A1Pyridazinones and methods of use thereofGOLDFINCH BIO INC·Filed 2021·Application pending·0 cites
- 1465US10745364B2Tetrahydronaphthyridine, benzoxazine, aza-benzoxazine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of diseaseMERCK SHARP & DOHME·Filed 2019·Granted Aug 18, 2020·0 cites·18 claims
- 1557US2025179013A1Inhibitors of rna helicase dhx9 and uses thereofACCENT THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1653US2024051985A1Mettl3 modulatorsACCENT THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1751US11623930B2Imidazodiazepinediones and methods of use thereofGOLDFINCH BIO INC·Filed 2019·Granted Apr 11, 2023·0 cites·10 claims
- 1849US2023027361A1Mettl3 modulatorsACCENT THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1948US2022389009A1Substituted 1,6-naphthyridine inhibitors of cdk5GOLDFINCH BIO INC·Filed 2020·Application pending·0 cites
- 2048US2024091303A1Biomarker-based treatment of focal segmental glomerulosclerosis and diabetic kidney diseaseGOLDFINCH BIO INC·Filed 2020·Application pending·0 cites
- 2141US12435078B2Pyridazinones and methods of use thereofGOLDFINCH BIO INC·Filed 2018·Granted Oct 7, 2025·0 cites·10 claims
- 2241US9233979B2Compounds that are ERK inhibitorsMERCK SHARP & DOHME·Filed 2013·Granted Jan 12, 2016·0 cites·16 claims
- 2341US9226922B2Compounds that are ERK inhibitorsMERCK SHARP & DOHME·Filed 2013·Granted Jan 5, 2016·0 cites·15 claims
- 2441US8999957B2Heterocyclic compounds as ERK inhibitorsDENG YONGQI·Filed 2011·Granted Apr 7, 2015·0 cites·15 claims
- 2540US2020377505A1Benzimidazoles and aza-benzimidazoles, and methods of use thereofGOLDFINCH BIO INC·Filed 2018·Application pending·0 cites
- 2640US2022152031A1Pyridazinones and methods of use thereofGOLDFINCH BIO INC·Filed 2020·Application pending·0 cites
- 2738US2013158041A1Tyrosine Kinase InhibitorsWILSON KEVIN·Filed 2011·Application pending·0 cites
- 2838US2013116231A1Tyrosine kinase inhibitorsWILSON KEVIN·Filed 2011·Application pending·0 cites
- 2936US8609897B2Trifluoromethylsulfonamide gamma secretase inhibitorDANIELS MATTHEW·Filed 2010·Granted Dec 17, 2013·0 cites·8 claims
- 3031US9227971B2Pyrazolo[1,5-a]pyrimidine compounds as mTOR inhibitorsSIDDIQUI M ARSHAD·Filed 2011·Granted Jan 5, 2016·0 cites·13 claims
- 3131US2012264735A1Tyrosine kinase inhibitorsYOUNG JONATHAN·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Matthew H. Daniels files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →